Education
MD, Chulalongkorn University Faculty of Medicine Thailand
PhD, Duke University
Honors and Awards
- Betty Dumaine Endowment Award
- Duke Scholars in Molecular Medicine in Neuroscience Track (2018)
- James B. Duke Fellowship
- 19th International Biology Olympiad in Mumbai, India, representing Thailand, Silver Medalist (2008)
- Prince Mahidol Award Youth Program Scholarship
- Chulalongkorn University and Peking University Scholarship
Research Interests
- Neurosurgery and neuro-oncology
- Basic science and translational research: Molecular genetics, targeted therapy in brain tumors, brain tumor immunotherapy
Hobbies
Cooking, traveling, and exploring new cultures
Residency Publications
Chongsathidkiet, P. & Fecci, P.E.. (2021, Sep). Cold-inducible RNA-binding protein (CIRBP) as a biomarker to predict recurrence of brain metastases. Neuro-oncology, 23(9), 1419-1420. Cited in PubMed; PMID: 34036364. Pub Status: Published.
Chongsathidkiet, P., Jackson, C., Koyama, S., Loebel, F., Cui, X., Farber, S., Woroniecka, K., Elsamadicy, A., Dechant, C., Kemeny, H., Sanchez-Perez, L., Cheema, T., Souders, N., Herndon, J., Coumans, J.V., Everitt, J., Nahed, B.V., et al., & Fecci, P.E.. (2018, Sep).Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors. Nature Medicine, 24(9),1459-1468. Cited in PubMed; PMID: 30104766. Pub Status: Published.
Ejikeme, T., de Castro, G.C., Ripple, K., Chen, Y., Giamberardino, C., Bartuska, A., Smilnak, G., Marius, C., Boua, J.V., Chongsathidkiet, P., Hodges, S., Pagadala, P., Verbick, L.Z., McCabe, A.R., & Lad, S.P.. (2020, Apr). Evaluation of neurapheresis therapy in vitro: a novel approach for the treatment of leptomeningeal metastases. Neuro-Oncology Advances, 2(1), 1-10. Cited in PubMed; PMID: 32642705. Pub Status: Published.
Elsamadicy, A.A., Chongsathidkiet, P., Desai, R., Woroniecka, K., Farber, S.H., Fecci, P.E., & Sampson, J.H.. (2017, Apr). Prospect of rindopepimut in the treatment of glioblastoma. Expert Opinion on Biological Therapy, 17(4), 507-513. Cited in PubMed; PMID: 28274144. Pub Status: Published.
Farber, S.H., Elsamadicy, A.A., Atik, A.F., Suryadevara, C.M., Chongsathidkiet, P., Fecci, P.E., & Sampson, J.H.. (2017, Mar). The Safety of available immunotherapy for the treatment of glioblastoma. Expert Opinion on Drug Safety, 16(3), 277-287. Cited in PubMed; PMID: 27989218. Pub Status: Published.
Grabowski, M.M., Sankey, E.W., Ryan, K.J., Chongsathidkiet, P., Lorrey, S.J., Wilkinson, D.S., & Fecci, P.E.. (2020, Jun). Immune suppression in gliomas. Journal of Neuro-Oncology, NA(NA), NA. Cited in PubMed; PMID: 32542437. Pub Status: Published.
Kemeny, H.R., Elsamadicy, A.A., Farber, S.H., Champion, C.D., Lorrey, S.J., Chongsathidkiet, P., Woroniecka, K., Cui, X., Shen, S., Rhodin, K.E., Tsvankin, V., Everitt, J., Sanchez-Perez, L., Healy, P., McLendon, R.E., Codd, P.J., Dunn, I.F., & Fecci P.E.. (2020, Mar). Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Clinical Cancer Research, 26(5), 1141-1151. Cited in PubMed; PMID: 31744830. Pub Status: Published.
Liu, Y., Chongsathidkiet, P., Crawford, B.M., Odion, R., Dechant, C.A., Kemeny, H.R., Cui, X., Maccarini, P.F., Lascola, C.D., Fecci, P.E., & Vo-Dinh, T.. (2019, Oct). Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory. Immunotherapy, 11(15), 1293-1302. Cited in PubMed; PMID: 31530200. Pub Status: Published.
Nayar, G., Ejikeme, T., Chongsathidkiet, P., Elsamadicy, A.A., Blackwell, K.L., Clarke, J.M., Lad, S.P., & Fecci, P.E.. (2017, Aug). Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget, 8(42), 73312-73328. Cited in PubMed; PMID: 29069871. Pub Status: Published.
Srinivasan, E.S., Sankey, E.W, Grabowski, M.M., Chongsathidkiet, P., & Fecci, P.E.. (2020, Jul). The intersection between immunotherapy and laser interstitial thermal therapy: a multipronged future of neuro-oncology. International Journal of Hyperthermia, 3 7(2), 27-34. Cited in PubMed; PMID: 32672126. Pub Status: Published.
Suryadevara, C.M., Desai, R., Abel, M.L., Riccione, K.A., Batich, K.A., Shen, S.H., Chongsathidkiet, P., Gedeon, P.C., Elsamadicy, A.A., Snyder, D.J., Herndon, J.E., Healy, P., Archer, G.E., Choi, B.D., Fecci, P.E., Sampson, J.H., & Sanchez-Perez, L.. (2018, Feb). Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma. Oncoimmunology, 7(6), e1434464. Cited in PubMed; PMID: 29872570. Pub Status: Published.
Woroniecka, K., Chongsathidkiet, P., Elsamadicy, A., Farber, H., Cui, X., & Fecci, P.E.. (2018, Feb). Flow Cytometric Identification of Tumor-Infiltrating Lymphocytes from Glioblastoma. Methods in Molecular Biology, 1741(NA), 221-226. Cited in PubMed; PMID: 29392704. Pub Status: Published.
Woroniecka, K., Chongsathidkiet, P., Rhodin, K., Kemeny, H., Dechant, C., Farber, S., Elsamadicy, A., Cui, X., Koyama, S., Jackson, C., Hansen, L., Johanns, T., Sanchez-Perez, L., Chandramohan, V., Yu, Y.A., Bigner, D.D., Giles, A., et al., & Fecci, P.E.. (2018, Sep). T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clinical Cancer Research, 24(17), 4175-4186. Cited in PubMed; PMID: 29437767. Pub Status: Published.
Woroniecka, K.I., Rhodin, K.E., Chongsathidkiet, P., Keith, K.A., & Fecci, P.E.. (2018, Aug). T-cell Dysfunction in Glioblastoma: Applying a New Framework. Clinical Cancer Research, 24(16), 3792-3802. Cited in PubMed; PMID: 29593027. Pub Status: Published.
Woroniecka, K.I., Rhodin, K.E., Dechant, C., Cui, X., Chongsathidkiet, P., Wilkinson, D., Waibl-Polania, J., Sanchez-Perez, L., & Fecci, P.E.. (2020, Mar). 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers. Clinical Cancer Research, 26(6), 1349-1358. Cited in PubMed; PMID: 31871298. Pub Status: Published.